Hamps Bio Limited (BOM:544312)
India · Delayed Price · Currency is INR 25.50
-0.40 (-1.54%)
At close: Sep 7, 2026
Hamps Bio Market Cap
Hamps Bio has a market cap or net worth of 225.64 million as of September 4, 2026. Its market cap has decreased by -13.67% in one year.
Market Cap
225.64M
Enterprise Value
292.77M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.50
ChartMarket Cap Chart
Since December 20, 2024, Hamps Bio's market cap has decreased from 443.18M to 225.64M, a decrease of -49.09%. That is a compound annual growth rate of -32.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 225.64M | 29.50% |
| Dec 29, 2025 | 174.24M | -51.61% |
| Dec 31, 2024 | 360.11M | -18.74% |
| Dec 20, 2024 | 443.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cian Healthcare | 334.75M |
| JFL Life Sciences | 325.00M |
| Rekvina Laboratories | 324.49M |
| Gujarat Terce Laboratories | 317.03M |
| Deccan Health Care | 297.27M |
| Welcure Drugs and Pharmaceuticals | 284.27M |
| Walpar Nutritions | 223.02M |
| Colinz Laboratories | 182.79M |